Bal Pharma In Jv Deal With Australian Firm
2026-10-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Roche Takes Natco to Supreme Court Over Generic Risdiplam Launch in India
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
-
Dow Chemical’s Freeport Plant Fire Contained; No Injuries Reported
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Bristol Myers Squibb Launches Mavacamten (“Kopozgo”) in India for Obstructive Hypertrophic Cardiomyopathy
-
Dow Europe Raises Polyurethane Prices in EMEA and India
-
BASF-Evonik Takeover Faces Political Resistance as German State Defends Jobs and Independence
-
$1.35 Billion! AkzoNobel to Sell Decorative Paints Business in Southeast Asia and Australia to Nippon Paint
-
Sinopec and CNAF to Implement Restructuring
Recommend Reading
-
Shell Polymers Explosion Caused About $95 Million in Damage, U.S. CSB Finds
-
BASF Sells Coatings Business for €7.7 Billion, Forming Independent Company with Carlyle
-
Evonik Reports Strong Q2 Results as Supply Chain Disruptions Boost Chemical Margins
-
Ineos Exits Sinopec Tianjin Joint Venture, Pays $120 Million "Breakup Fee"
-
Kuraray Exits China’s PMMA Market, with Jiangsu Shuangxiang Group Taking Over
-
Business Society LLDPE Daily Review: Weak Fluctuations on August 7, 2026
-
Business Society September 20, 2026 DOP Trend Analysis: Clearly Downward
-
Low Inventory and Reduced Supply Trigger Price Hikes for Acrylonitrile in the Off-Season in China
-
Business Society’s Lithium Carbonate Trend Analysis for September 20, 2026: Clearly Upward
-
U.S. Formally Imposes Antidumping and Countervailing Duty Orders on Chinese L-Lysine